日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts.

AML获得性多药耐药是由复发性髓母细胞凋亡启动不足引起的

Olesinski Elyse A, Bhatia Karanpreet Singh, Wang Chuqi, Pioso Marissa S, Lin Xiao Xian, Mamdouh Ahmed M, Ng Shu Xuan, Sandhu Vedant, Jasdanwala Shaista Shabbir, Yilma Binyam, Bohl Stephan, Ryan Jeremy A, Malani Disha, Luskin Marlise R, Kallioniemi Olli, Porkka Kimmo, Adamia Sophia, Chng Wee Joo, Osato Motomi, Weinstock David M, Garcia Jacqueline S, Letai Anthony, Bhatt Shruti

Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with MLL rearrangement or NPM1 mutation to venetoclax

Menin抑制剂ziftomenib (KO-539) 与靶向染色质调控或细胞凋亡的药物具有协同作用,并能增强MLL重排或NPM1突变的急性髓系白血病对维奈托克的敏感性。

Rausch, Johanna; Dzama, Margarita M; Dolgikh, Nadezda; Stiller, Hanna L; Bohl, Stephan R; Lahrmann, Catharina; Kunz, Kerstin; Kessler, Linda; Echchannaoui, Hakim; Chen, Chun-Wei; Kindler, Thomas; Döhner, Konstanze; Burrows, Francis; Theobald, Matthias; Sasca, Daniel; Kühn, Michael W M

The Differential Diagnosis and Treatment of Thrombotic Microangiopathies

血栓性微血管病的鉴别诊断和治疗

Bommer, Martin; Wölfle-Guter, Manuela; Bohl, Stephan; Kuchenbauer, Florian